• Research & Development

  Standford University Med School to Host Levosimendan Phase 2 Trial

  Posted by Pulmonary Hypertension News Moderator on November 30, 2018 at 1:12 pm

  Stanford University School of Medicine is the first clinical site for a Phase 2 trial testing Tenax’s levosimendan candidate for the treatment of PH-HFpEF. Click here to read more.

  What other clinical trials are you interested in reading about?

  replied 7 years, 3 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply